SASP and Aging: Senescence-Associated Secretory Phenotype Explained
What Is SASP?
SASP (senescence-associated secretory phenotype) refers to the complex mixture of pro-inflammatory cytokines, chemokines, growth factors, and proteases secreted by senescent cells¹.
Instead of being cleared efficiently, senescent cells accumulate with age and use SASP signaling to promote chronic, low-grade inflammation, often referred to as inflammaging.
This persistent inflammatory signaling contributes to tissue damage, impaired stem cell function, and the development of age-related diseases¹.
Biological Role of SASP
SASP is not inherently harmful. In early or acute contexts, it plays a beneficial role in tissue repair and cellular communication.
It helps recruit immune cells to remove damaged or dysfunctional cells and supports processes such as wound healing and tissue remodeling².
However, with aging, this system becomes dysregulated.
Immune System Dysregulation
Over time, the immune system becomes less efficient at clearing senescent cells.
As a result, SASP signaling persists instead of resolving.
This leads to chronic immune activation, reduced immune surveillance, and accumulation of senescent cells, further amplifying dysfunction².
SASP as a Driver of Chronic Inflammation
SASP is a major contributor to systemic, low-grade inflammation.
It drives the release of inflammatory mediators that are linked to many age-related conditions, including cardiovascular disease, metabolic dysfunction, and. neurodegeneration³.
This chronic inflammatory state is a central hallmark of aging.
Tissue Dysfunction and Structural Damage
SASP factors include enzymes such as matrix metalloproteinases that degrade extracellular matrix components.
This disrupts tissue structure, reduces regenerative capacity, and impairs organ function over time⁴.
The result is progressive loss of tissue integrity and resilience.
Spreading Senescence
One of the most important features of SASP is its ability to induce senescence in neighboring healthy cells.
This creates a self-reinforcing feedback loop where senescence spreads through tissues, accelerating aging at the cellular and tissue level⁵.
SASP as a Therapeutic Target
Because of its central role in aging biology, SASP is a major target for longevity interventions.
Strategies include senolytics, which selectively remove senescent cells, and SASP modulators, which reduce inflammatory signaling without necessarily eliminating the cells themselves⁶.
These approaches aim to reduce inflammation, improve tissue function, and support overall healthspan.
Summary - Why SASPs Matters for Longevity
SASP sits at the intersection of inflammation, cellular senescence, and tissue dysfunction.
While short-term SASP activity can be beneficial, chronic activation drives persistent inflammation, cellular damage, and functional decline⁷.
From a longevity perspective, managing SASP activity is critical for maintaining tissue integrity, reducing inflammatory burden, and slowing the progression of age-related disease.

Footnotes
1 Senescence-associated secretory phenotype (SASP) https://pubmed.ncbi.nlm.nih.gov/30726765/
2 Senescent cells in ageing and disease https://pubmed.ncbi.nlm.nih.gov/31123340/
3 Inflammaging and age-related disease https://pubmed.ncbi.nlm.nih.gov/29676996/
4 Cellular senescence and tissue remodeling https://pubmed.ncbi.nlm.nih.gov/30053260/
5 Paracrine senescence and SASP https://pubmed.ncbi.nlm.nih.gov/30053259/
6 Senolytics in aging and disease https://pubmed.ncbi.nlm.nih.gov/32020759/
7 Roles of senescent cells in tissue repair https://pubmed.ncbi.nlm.nih.gov/30053258/
